Cargando…

Co-Expression of Androgen Receptor and Cathepsin D Defines a Triple-Negative Breast Cancer Subgroup with Poorer Overall Survival

Background: In the triple-negative breast cancer (TNBC) group, the luminal androgen receptor subtype is characterized by expression of androgen receptor (AR) and lack of estrogen receptor and cytokeratin 5/6 expression. Cathepsin D (Cath-D) is overproduced and hypersecreted by breast cancer (BC) cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mansouri, Hanane, Alcaraz, Lindsay B., Mollevi, Caroline, Mallavialle, Aude, Jacot, William, Boissière-Michot, Florence, Simony-Lafontaine, Joelle, Laurent-Matha, Valérie, Roger, Pascal, Liaudet-Coopman, Emmanuelle, Guiu, Séverine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281089/ https://www.ncbi.nlm.nih.gov/pubmed/32429078 http://dx.doi.org/10.3390/cancers12051244

Ejemplares similares

SPARC in cancer‐associated fibroblasts is an independent poor prognostic factor in non‐metastatic triple‐negative breast cancer and exhibits pro‐tumor activity
por: Alcaraz, Lindsay B., et al.
Publicado: (2022)

A 9-kDa matricellular SPARC fragment released by cathepsin D exhibits pro-tumor activity in the triple-negative breast cancer microenvironment
por: Alcaraz, Lindsay B, et al.
Publicado: (2021)

Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple negative breast cancer and correlation with other biomarkers
por: Guiu, Séverine, et al.
Publicado: (2018)

Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies
por: Ashraf, Yahya, et al.
Publicado: (2019)

BRCA1 Promoter Hypermethylation is Associated with Good Prognosis and Chemosensitivity in Triple-Negative Breast Cancer
por: Jacot, William, et al.
Publicado: (2020)

Prognostic Value of HER2-Low Expression in Non-Metastatic Triple-Negative Breast Cancer and Correlation with Other Biomarkers
por: Jacot, William, et al.
Publicado: (2021)

Clinicopathological Correlates of γδ T Cell Infiltration in Triple-Negative Breast Cancer
por: Boissière-Michot, Florence, et al.
Publicado: (2021)

Quantification of HER1, HER2 and HER3 by time-resolved Förster resonance energy transfer in FFPE triple-negative breast cancer samples
por: Ho-Pun-Cheung, Alexandre, et al.
Publicado: (2019)

CXCR2 Levels Correlate with Immune Infiltration and a Better Prognosis of Triple-Negative Breast Cancers
por: Boissière-Michot, Florence, et al.
Publicado: (2021)

Correlation of the TIGIT-PVR immune checkpoint axis with clinicopathological features in triple-negative breast cancer
por: Boissière-Michot, Florence, et al.
Publicado: (2022)

Studying the Genomic Role of Cathepsin-D in ER(+) Breast Cancer
por: Dianati, Elham, et al.
Publicado: (2021)

Catalytically inactive human cathepsin D triggers fibroblast invasive growth
por: Laurent-Matha, Valérie, et al.
Publicado: (2005)

Association of CD206 Protein Expression with Immune Infiltration and Prognosis in Patients with Triple-Negative Breast Cancer
por: Bobrie, Angélique, et al.
Publicado: (2022)

Diversity of Tumor-Infiltrating, γδ T-Cell Abundance in Solid Cancers
por: Chabab, Ghita, et al.
Publicado: (2020)

Nuclear cathepsin D enhances TRPS1 transcriptional repressor function to regulate cell cycle progression and transformation in human breast cancer cells
por: Bach, Anne-Sophie, et al.
Publicado: (2015)

Prognostic Value of CXCR2 in Breast Cancer
por: Boissière-Michot, Florence, et al.
Publicado: (2020)

Cathepsin-D, a Key Protease in Breast Cancer, Is Up-Regulated in Obese Mouse and Human Adipose Tissue, and Controls Adipogenesis
por: Masson, Olivier, et al.
Publicado: (2011)

Neutrophil to Lymphocyte Ratio as Prognostic and Predictive Factor in Breast Cancer Patients: A Systematic Review
por: Corbeau, Iléana, et al.
Publicado: (2020)

High PTPN13 expression in high grade serous ovarian carcinoma is associated with a better patient outcome
por: D’Hondt, Véronique, et al.
Publicado: (2017)

Reverse transcription-quantitative polymerase chain reaction: description of a RIN-based algorithm for accurate data normalization
por: Ho-Pun-Cheung, Alexandre, et al.
Publicado: (2009)

PTPN13 induces cell junction stabilization and inhibits mammary tumor invasiveness
por: Hamyeh, Mohamed, et al.
Publicado: (2020)

Comment on ‘Histopathologic evaluation of liver metastases from colorectal cancer in patients treated with FOLFOXIRI plus bevacizumab'
por: Bibeau, F, et al.
Publicado: (2013)

Pharmacokinetic Variability Drives Palbociclib-Induced Neutropenia in Metastatic Breast Cancer Patients: Drug–Drug Interactions Are the Usual Suspects
por: Leenhardt, Fanny, et al.
Publicado: (2022)

Inflammatory Blood Markers as Prognostic and Predictive Factors in Early Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
por: Corbeau, Ileana, et al.
Publicado: (2020)

National Insurance and the Poorer Hospitals
Publicado: (1914)

The Syk Kinase Promotes Mammary Epithelial Integrity and Inhibits Breast Cancer Invasion by Stabilizing the E-Cadherin/Catenin Complex
por: Kassouf, Toufic, et al.
Publicado: (2019)

THE ESTIMATION OF CATHEPSIN WITH HEMOGLOBIN AND THE PARTIAL PURIFICATION OF CATHEPSIN
por: Anson, M. L.
Publicado: (1937)

A Plea for Sanatoria for the Poorer Consumptives
por: Weatherly, Lionel A.
Publicado: (1900)

Deprivation amplification revisited; or, is it always true that poorer places have poorer access to resources for healthy diets and physical activity?
por: Macintyre, Sally
Publicado: (2007)

THE PURIFICATION OF CATHEPSIN
por: Anson, M. L.
Publicado: (1940)

Are Psychotic Experiences Related to Poorer Reflective Reasoning?
por: Mækelæ, Martin J., et al.
Publicado: (2018)

DRIVING CESSATION IS ASSOCIATED WITH POORER MENTAL HEALTH
por: Stinchcombe, Arne, et al.
Publicado: (2019)

Poorer sleep impairs brain health at midlife
por: Namsrai, Tergel, et al.
Publicado: (2023)

Hypnosis on patients treated with adjuvant chemotherapy for breast cancer: A feasibility study
por: Fabbro, Michel, et al.
Publicado: (2022)

Do poorer people have poorer access to local resources and facilities? The distribution of local resources by area deprivation in Glasgow, Scotland()
por: Macintyre, Sally, et al.
Publicado: (2008)

Differential Regulation of Cathepsin S and Cathepsin L in Interferon γ–treated Macrophages
por: Beers, Courtney, et al.
Publicado: (2003)

Plasma Cathepsin S and Cathepsin S/Cystatin C Ratios Are Potential Biomarkers for COPD
por: Nakajima, Takahiro, et al.
Publicado: (2016)

Expression and significance of cathepsin C and cathepsin D during pregnancy and Preeclampsia
por: Song, Jingzhe, et al.
Publicado: (2023)

Decision of Adjuvant Systemic Treatment in HR+ HER2- Early Invasive Breast Cancer: Which Biomarkers Could Help?
por: Alexandre, Marie, et al.
Publicado: (2019)

Cathepsins in digestive cancers
por: Chen, Siyuan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9mv11qkch2kat8sftbd62l3gck